Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer

Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer

10.1093/annonc/mdy245

Saved in:

Bibliographic Details
Main Authors:	Basu, B, Krebs, MG, Sundar, R, Wilson, RH, Spicer, J, Jones, R, Brada, M, Talbot, DC, Steele, N, Garces, AH Ingles, Brugger, W, Harrington, EA, Evans, J, Hall, E, Tovey, H, de Oliveira, FM, Carreira, S, Swales, K, Ruddle, R, Raynaud, FI, Purchase, B, Dawes, JC, Parmar, M, Turner, AJ, Tunariu, N, Banerjee, S, de Bono, JS, Banerji, U
Other Authors:	MEDICINE
Published:	OXFORD UNIV PRESS 2021
Subjects:	phase 1 m-TORC1/m-TORC2 inhibitor combination therapy ovarian cancer squamous non-small-cell lung cancer
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/206997
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Description
Summary:	10.1093/annonc/mdy245